Oxymorphone-3-methoxynaltrexonazine
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
(7Z)-7-[(Z)-[3-(cyclopropylmethyl)-4a-hydroxy-9-methoxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ylidene]hydrazinylidene]-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol
|
|
Identifiers | |
CAS Number | 110320-72-4 |
PubChem | CID 9589378 |
ChemSpider | 7863525 |
Chemical data | |
Formula | C38H44N4O6 |
Molar mass | 652.79 g·mol−1 |
3D model (Jmol) | Interactive image |
|
|
|
Oxymorphone-3-methoxynaltrexonazine (OM-3-MNZ) is a morphinan-based opioid that acts as a selective μ-opioid receptor agonist, unlike the closely related mixed agonist-antagonist Oxymorphonenaltrexonazine.[1]
See also[edit]
References[edit]
- ^ Steven Galetta; Elliot F. Hahn; Steve Nishimura; Gavril W. Pasternak (August 1987). "Oxymorphone-naltrexonazine, a mixed opiate agonist-antagonist". Life Sciences. 41 (6): 783–787. doi:10.1016/0024-3205(87)90459-0. PMID 2441221.
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |